SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
Report of Foreign Private Issuer
 
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
 
June 30, 2023 
 
Commission File Number 001-14978
 
SMITH & NEPHEW plc
(Registrant's name)
 
Building 5, Croxley Park,
Hatters Lane, Watford, Hertfordshire, WD18 8YE,
England
 
(Address of registrant's principal executive offices)
 
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
 
Form 20-F X                Form 40-F
    ---                               ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
 
Yes                        No X
---                         ---
 
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
 
Yes                      No X
---                         ---
[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
 
Yes                  No X
---                   ---
 
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
 
 
 
 
 
 
Smith & Nephew plc - Director Declaration
 
 
 
30 June 2023
 
 
 
In accordance with Listing Rule 9.6.14, Smith & Nephew plc (the "Company") announces that Angie Risley, an Independent Non-Executive Director and Chair of the Remuneration Committee of the Company, is to be appointed to the board of InterContinental Hotels Group PLC as a non-executive director effective from 1 September 2023 and as Chair of their Remuneration Committee effective from 1 January 2024.
 
 
Enquiries
 
Investors / Analysts
Andrew Swift
Smith+Nephew
 
 
+44 (0) 1923 477433
 
Media
Charles Reynolds
Smith+Nephew
 
 
+44 (0) 1923 477314
 
 
 
 
About Smith+Nephew
 
 
Smith+Nephew is a portfolio medical technology company that exists to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 18,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.
 
 
Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $5.2 billion in 2021. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms 'Group' and 'Smith+Nephew' are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.
 
For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on Twitter, LinkedIn, Instagram or Facebook.
 
 
 
 
 
 
 
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Smith & Nephew Plc
(Registrant)
 
 
Date: June 30, 2023
 
 
By: /s/ Helen Barraclough
-----------------
                                                                                                                              Helen Barraclough
                                                                                                                      Company Secretary
 
 
Smith and Nephew (PK) (USOTC:SNNUF)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Smith and Nephew (PK) Charts.
Smith and Nephew (PK) (USOTC:SNNUF)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Smith and Nephew (PK) Charts.